Denis Breuille

This inventor holds 25 USPTO granted patents and 31 published patent applications, plus 14 CIPO patents and 16 EPO patents, primarily in Nutritional Biotechnology. Top assignees: Nestec S.a., Societe Des Produits Nestle S.a., Institut De La Research Agronomique. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Breuille. Retrieved from https://idiyas.com/inventor/denis-breuille

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 31)

% Patents Active = 88.0

CIPO Patents = 14 (Patent Applications = 10)

EPO Patents = 16 (Patent Applications = 37)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 138(Granted Patents)

Location History:

Saint-Saturnin, FR (1998 - 2010)
Lausanne, FR (2013)
Epalinges, CH (2016 - 2018)
Lausanne, CH (2016 - 2024)

Company Filing History:

Societe Des Produits Nestle S.a.

patents

1 out of 1

Institut De La Research Agronomique

patent

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Amino Acids

Muscle Recovery

Sarcopenia

Diabetes Treatment

Nutritional Composition

Polyphenols

Metabolic Syndrome

Endurance Nutrition

Microbiota Health

IBD Treatment

Citrulline

Leucine

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576068 - Compositions containing amino acids and methods of using such compositions for treating sarcopenia (2026-03-17),

2. 12059016 - Complexes of whey protein micelles and pectin and body muscle protein synthesis (2024-08-13),

3. 11957652 - Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome (2024-04-16),

4. 11813273 - Compositions and methods using a polyphenol for musculoskeletal health (2023-11-14),

5. 11614442 - Method for determining the distinctive nutritional requirements of a patient (2023-03-28),

6. 11419838 - Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome (2022-08-23),

7. 11364254 - Compositions and methods using a polyphenol for musculoskeletal health (2022-06-21),

8. 11123407 - Nutritional composition for treating or preventing impaired mobility (2021-09-21),

9. 10772558 - Assessment and advice on nutrition, endurance, and strength (2020-09-15),

10. 10768169 - Method for determining the distinctive nutritional requirements of a patient (2020-09-08),

11. 10751357 - Compositions and methods using a polyphenol for musculoskeletal health (2020-08-25),

12. 10744100 - Compositions and methods using a polyphenol for musculoskeletal health (2020-08-18),

13. 10137108 - Nutritional composition useful in the treatment of IBD patients (2018-11-27),

14. 9913818 - Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome (2018-03-13),

15. 9884033 - Amino acid supplementation for a healthy microbiota ecosystem (2018-02-06),

Title: Denis Breuille: A Pioneer in Muscle Protein Research

Introduction

Denis Breuille, based in Lausanne, Switzerland, is a distinguished inventor with an impressive portfolio of 24 patents. His innovative work focuses primarily on the fields of muscle protein synthesis, metabolic syndrome, and diabetes, showcasing his commitment to advancing health and nutrition through scientific research.

Latest Patents

Among his latest patents, Breuille has developed remarkable compositions aimed at treating or preventing conditions related to reduced muscle mass. One notable invention involves a composition of whey protein micelles and pectin, designed to address issues such as sarcopenia, muscle atrophy, and negative nitrogen balance. This invention emphasizes the efficacy of combining these components for enhancing muscle protein synthesis.

Additionally, he has patented compositions that incorporate citrulline and leucine, highlighting their potential in treating diabetes and metabolic syndrome. By including metabolites like hydroxyisocaproic acid (HICA) and beta-hydroxy-beta-methylbutyrate (HMB), these compositions aim to provide a synergistic approach to managing pre-diabetes and related conditions.

Career Highlights

Denis Breuille has enjoyed a noteworthy career, contributing to significant advancements in nutrition and health. He has worked with leading companies in the industry, including Nestec S.A. and Société des Produits Nestlé S.A. His research has influenced nutritional guidelines and therapeutic approaches in the field of muscle health and metabolic disorders.

Collaborations

Throughout his career, Breuille has collaborated with esteemed colleagues, including Magali Faure and Marie Noelle Horcajada. These partnerships have fostered innovation and the development of groundbreaking research, reinforcing the importance of teamwork in scientific discovery.

Conclusion

Denis Breuille's contributions to the fields of muscle protein synthesis and metabolic health are invaluable. His extensive patent portfolio and collaborative efforts illustrate a dedication to improving health outcomes through innovative solutions. As he continues to push the boundaries of research, Breuille remains a significant figure in the realm of nutritional science and invention.

Profile summary based on public USPTO records.